(Reuters) - Gene therapy maker Bluebird bio said on Friday it would be taken private by Carlyle and SK Capital Partners, ...

Trump administration orders and directives have some in the construction sector optimistic, but actions are disrupting government functions with impacts feared for industry operations, costs and risks ...